G1 Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference and the 34th Annual Roth 2022 Conference

Rhea-AI Summary

G1 Therapeutics, a commercial-stage oncology company, announced its participation in two investor conferences in March 2022. On March 8, CEO Jack Bailey will join a New Drug Launches panel at the Cowen Health Care Conference. Following this, on March 15, Bailey and CMO Raj Malik will engage in a fireside chat at the Roth Conference. Both events will be accessible via webcast on the company's events page. G1 is focused on enhancing cancer treatments with its product COSELA and has a robust pipeline for various solid tumors.

RESEARCH TRIANGLE PARK, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company will participate in two upcoming investor conferences in March 2022.

• On Tuesday March 8, 2022, G1’s Chief Executive Officer Jack Bailey will participate in a New Drug Launches panel at 2:10PM ET during the virtual 42^nd Annual Cowen Health Care Conference.
  
  
• On Tuesday March 15, 2020, Jack Bailey and Raj Malik, M.D., G1’s Chief Medical Officer, will participate in a fireside chat at 8:00AM PT during the 34^th Annual Roth Conference.
  

The webcast and replay of both events will be accessible on the Events & Presentations page of http://www.g1therapeutics.com.

About G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (trilaciclib). G1 has a deep clinical pipeline and is executing a tumor-agnostic development plan evaluating COSELA in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

Contacts:
Will Roberts
Vice President, Investor Relations & Corporate Communications
919-907-1944
wroberts@g1therapeutics.com

FAQ

What is G1 Therapeutics participating in March 2022?

G1 Therapeutics will participate in two investor conferences: the Cowen Health Care Conference on March 8 and the Roth Conference on March 15.

Who is speaking at the Cowen Health Care Conference for G1 Therapeutics?

CEO Jack Bailey will represent G1 Therapeutics in a New Drug Launches panel at the Cowen Health Care Conference.

When is G1 Therapeutics' fireside chat scheduled?

The fireside chat featuring CEO Jack Bailey and CMO Raj Malik is on March 15, 2022, at 8:00 AM PT.

Where can I access G1 Therapeutics' conference webcasts?

The webcasts for both conferences can be accessed on G1 Therapeutics' Events & Presentations page.

What is the focus of G1 Therapeutics' product COSELA?

COSELA is aimed at improving the treatment of various solid tumors, including colorectal, breast, lung, and bladder cancers.